H. Mogul

发表

Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women.

H. Burke, S. Wilker, S. Gambert, 1996, The Journal of clinical endocrinology and metabolism.

Consensus statement - Prader-Willi syndrome: Growth hormone (GH)/insulin-like growth factor axis deficiency and GH treatment

D. Wilson, M. Cappa, G. Chiumello, 2000 .

Growth Hormone and Prader-Willi Syndrome

Phillip D. K. Lee, A. Carrel, H. Mogul, 2006 .

Growth Hormone Treatment of Adults with Prader Willi Syndrome and Growth Hormone Deficiency Improves Lean Body Mass , Fractional Body Fat , and Serum Triiodothyronine Without Glucose Impairment : Results From The US Multi-Center Trial

Phillip D. K. Lee, A. Southren, B. Whitman, 2008 .

Obesity: new perspectives and pharmacotherapies.

W. Frishman, S. Peterson, H. Mogul, 2006, Cardiology in review.

New Perspectives and Pharmacotherapies

W. Frishman, S. Peterson, H. Mogul, 2006 .

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

John J. Kopchick, Véronique Beauloye, Jens Sandahl Christiansen, 2013, The Journal of clinical endocrinology and metabolism.

METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN.

R. Freeman, H. Mogul, Khoa Nguyen, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.

Phillip D. K. Lee, A. Southren, B. Whitman, 2008, The Journal of clinical endocrinology and metabolism.

Carbohydrate Modified Diet & Insulin Sensitizers Reduce Body Weight & Modulate Metabolic Syndrome Measures in EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance): A Randomized Trial of Normoglycemic Women with Midlife Weight Gain

R. Freeman, H. Mogul, M. Frey, 2014, PloS one.

Metformin and carbohydrate-modified diet: a novel obesity treatment protocol: preliminary findings from a case series of nondiabetic women with midlife weight gain and hyperinsulinemia.

A. Southren, S. Peterson, B. Weinstein, 2001, Heart disease.

Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (Syndrome W).

A. Southren, S. Peterson, B. Weinstein, 2003, Heart disease.

Syndrome W: a new model of hyperinsulinemia, hypertension and midlife weight gain in healthy women with normal glucose tolerance.

A. Southren, S. Peterson, S. Gambert, 2002, Heart disease.

Long-term hormonal adaptations to weight loss

R. Freeman, H. Mogul, Feras Hantash, 2012 .

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

S. Radovick, R. Battista, K. Chihara, 2013, The Journal of clinical endocrinology and metabolism.